First Trust NYSE Arca Biotechnology Index Fund (FBT)

NYSEARCA: FBT · Real-Time Price · USD
219.26
+4.39 (2.04%)
Jun 3, 2026, 12:47 PM EDT - Market open
Assets$2.55B
Expense Ratio0.55%
PE Ratio25.31
Shares Out11.55M
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
Payout Frequencyn/a
Payout Ration/a
Volume9,157
Open214.12
Previous Close214.87
Day's Range214.12 - 219.17
52-Week Low157.52
52-Week High224.94
Beta0.67
Holdings33
Inception DateJun 19, 2006

About FBT

Fund Home Page

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is issued by First Trust.

Asset Class Equity
Category Health
Region North America
Stock Exchange NYSEARCA
Ticker Symbol FBT
ETF Provider First Trust
Index Tracked NYSE Arca Biotechnology Index

Top 10 Holdings

41.30% of assets
NameSymbolWeight
Corcept Therapeutics IncorporatedCORT5.10%
Bruker CorporationBRKR4.72%
Veracyte, Inc.VCYT4.70%
Illumina, Inc.ILMN4.12%
NeoGenomics, Inc.NEO4.12%
Axsome Therapeutics, Inc.AXSM3.92%
Alkermes plcALKS3.84%
Neurocrine Biosciences, Inc.NBIX3.79%
Arrowhead Pharmaceuticals, Inc.ARWR3.50%
Krystal Biotech, Inc.KRYS3.49%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 13, 2024$1.1726Dec 31, 2024
Sep 23, 2015$0.0197Sep 30, 2015
Jun 24, 2015$0.0649Jun 30, 2015
Mar 25, 2015$0.0476Mar 31, 2015
Dec 23, 2014$0.0524Dec 31, 2014
Jun 23, 2008$0.2697Jun 30, 2008
Full Dividend History

Performance

FBT had a total return of 33.23% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.75%.

News

Here are the top-performing ETFs in first half of 2023 as crypto-related funds soar

Hello! This week's ETF Wrap looks at top performers in the first half of 2023, as well as flows, as stocks rally and crypto-related funds jump so far this year.

3 years ago - Market Watch

Biotech ETFs at multi-week highs, extending winning streak

Biotechnology exchange-traded funds outperformed Tuesday as investors focused on next-generation solutions to the coronavirus and more. The ARK Genomic Revolution ETF was up 2.2% in the early afternoo...

Other symbols: BBHIBBXBI
6 years ago - Market Watch

Biotech ETFs at two-week highs on upbeat vaccine news

Biotech exchange-traded funds got a bounce Friday from bullish news on coronavirus treatments. The ALPS Medical Breakthroughs ETF , the ARK Genomic Revolution ETF , and the First Trust NYSE Arca Biote...

Other symbols: ARKGSBIO
6 years ago - Market Watch

Biotech stocks fall after Trump promises executive order drug prices

CNBC's Meg Tirrell reports on the dip in biotech stocks after President Donald Trump promised that an executive order on drug prices is coming.

7 years ago - CNBC Television

Is now the time to buy Nike? What about biotech? #AskHalftime

The "Halftime Report" traders take viewer questions on Nike and biotech.

Other symbols: IBBNKEXBI
8 years ago - CNBC Television